CompletedPhase 1NCT02140983

Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stanford University
Principal Investigator
Natalie Rasgon, M.D., Ph.D.
Stanford University
Intervention
Liraglutide(drug)
Enrollment
41 target
Eligibility
50-70 years · All sexes
Timeline
20132017

Study locations (1)

Collaborators

American Diabetes Association

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02140983 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials